Risk factors for hepatocellular carcinoma in Egypt: The role of hepatitis-B viral infection and schistosomiasis

Anticancer Research

Volumn 19, Issue 5 C, 1999, Pages 4565-4569

  Badawi, Alaa F ^a   Michael, Michael S ^b  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b Novexpharma   (Canada)

Author keywords

Biomarkers; Egypt; Hepatitis; Liver cancer; Schistosomiasis; Smoking

Indexed keywords

PESTICIDE;

ADULT; AGE; AGRICULTURAL WORKER; ARTICLE; CANCER RISK; CIGARETTE SMOKING; DEMOGRAPHY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SCHISTOSOMIASIS;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EGYPT; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SCHISTOSOMIASIS;

EID: 0033452563     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Badawi AF, Mostafa MH, Probert A and O'Connor PJ: Role of schistosomiasis in human bladder cancer: evidence of association, etiological factors and basic mechanisms of carcinogenesis. Eur J Cancer Prevent 4: 45-59, 1995.
2. Ghaffar YA, Fattah SA, Kamel M, Badr RM, Mohamed FF and Strickland GT: The impact of endemic schistosomiasis on acute viral hepatitis. Am J Trop Med Hyg 45: 743-750, 1991.
3. Badawi AF and Mostafa MH: Schistosomiasis: Health and socioeconomic aspects in the Egyptian environment. Ramazzini Newslett 3: 33-44, 1992.
4. Hyams KC, El-Alamy MA, Pazzaglia G, El-Ghorab NM, Sidhom O, Habib M and Dunn MA: Risk of hepatitis B infection among Egyptians infected with Schistosoma mansoni. Am J Trop Med Hyg 35: 1035-1039, 1986.
5. Rubin E and Farber JL: Pathology, 2nd ed. Philadelphia, PA, J.B. Lippincott Co, 1994.
6. Domingo EO, Warren KS and Stenger AJ: Increased incidence of hepatoma in mice with chronic schistosomiasis and treated with a carcinogen. Am J Pathol 5: 307-321, 1967.
7. Badawi AF, Cooper DP, Mostafa MH, Doenhoff MJ, Probert A, Padriac F, Cooper R and O'Connor PJ: Promutagenic methylation damage in liver DNA of mice infected with Schistosoma mansoni. Carcinogenesis 14: 653-657, 1993.
8. Badawi AF and Mostafa MH: Possible mechanisms of alteration in the capacities of carcinogen-metabolizing enzymes during schistosomiasis and their role in bladder cancer induction. Int J Med Res 21: 281-395, 1993.
9. Bassily S, Dunn MA, Farid A, Kilpatrick ME, el-Masry NA, Kamel IA and Murphy BL: Chronic hepatitis B in patients with schistosomiasis mansoni. J Trop Med Hyg 86: 67-71, 1983.
10. Ghaffar YA, el-Chazli Y, Madwar M and Khalil A: Relationship of schistosomiasis to hepatitis-B infection and its effect on the severity of the hepatic lesions. Egypt J Gastroenterol 10: 21-27, 1984.
11. Madwar MA, Tahawy ME and Strickland GT: The relationship between uncomplicated schistosomiasis and hepatitis B infection. Trans Royal Soc Trop Med Hyg 83: 233-236, 1989.
12. Mokhtar N: Cancer Pathology Registry (1985-1989): National Cancer Institute, Cairo, Cairo University, NCI Publ, 1991.
13. Saeed AA, Al-Admawi AM, Al-Rasheed A, Fairclough D, Bacchus R and Ring C: Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 338: 459-460, 1991.
14. Neilson JO, Dietrichson O, Elling P and Christofferson P: Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Eng J Med 285: 1157-1160, 1971.
15. Szmuness W: Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 24: 40-69, 1978.
16. Ellner JJ, Olds GR and Kamel DL: Suppression of splenic T lymphocytes in human hepatosplenic schistosomiasis mansoni. J Immunol 125: 308-312, 1980.
17. El-Alamy MA and Cline BL: Prevalence. of Schistosoma haemalobium and Schistosoma mansoni infection in Qalyub, Egypt. Am J Trop Med Hyg 26: 470-472, 1977.
18. Ratliff C and Hall F: Laboratory manual of clinical biochemistry. Tample, TX, Scatt and White Memorial Hospital Publ Co, 1973.
19. Go VL and Zamcheck N: The role of tumor markers in the management of colorectal cancer. Cancer 50: 2618-2623, 1982.
20. Hurley JP, Haagensen DE Jr, Hansen HJ and Zamcheck N: Capture and detection of carcinoembryonic antigen on antibody coated beads used in enzyme immunoassay. J Immunoassay 7: 309-336, 1986.
21. Nagaratnam N, Ramachandra V, Jiffy AJ and Bhuvanendran N: Primary liver cancer in Sri Lanka. J Trop Med Hyg 87: 185-187, 1984.
22. Chan KT: The management of primary carcinoma of the liver. Ann R Coll Surg Engl 41: 253-282, 1967.
23. Smalley S, Moretel C, Hilton H and Weiland L: Hapatoma in the non-cirrhotic livers. Cancer 62: 414-418, 1989.
24. Okuda K: The liver cancer study group of Japan. Primary liver cancer in Japan. Cancer 45: 2663-2669, 1987.
25. Maussier ML, Valenza V, Schinco G and Gallis G: AFP, CEA, CA 19-9, TPA in hepatocellular carcinoma. Int J Biol Markers 5: 121-126, 1990.
26. Nommura F, Ohnushi K and Tanaba Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum AFP levels. Cancer 64: 1700-1707, 1989.
27. London WT, Evans AA, Buetow K, Litwin S, McGlynn K, Zhou T, Clapper M, Ross E, Wild C and Shen FM: Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal. Princess Takamatsu Symp 25: 51-60, 1995.
28. Shibata A, Fukuda K, Toshima H, Tashiro H and Hirohata T: The role of cigarette smoking and drinking in the development of liver cancer: 28 years of observations on male cohort members in a farming and fishing area. Cancer Detect Prev 14: 617-623, 1990.
29. Shibata A, Hirohata T, Toshima H and Tashiro H: The role of drinking and cigarette smoking in the excess deaths from liver cancer. Jpn J Cancer Res 77: 287-295, 1986.
30. Brownson RC, Reif JS, Chang JC and Davis JR: Cancer risks among Missouri farmers. Cancer 64: 2381-2386, 1989.
31. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD and Cole P: Case-control study of hepatocellular carcinoma, occupation and chemical exposure. J Occup Med 29: 665-669, 1987.
32. Itoshima T, Fedail SS, Suliman I, Ali AK, Higashi T and Tsuji T: Hepatitis B virus markers in patients with schistosomiasis, liver cirrhosis and hepatocellular carcinoma in Khartoum, Sudan. Acta Med Okyama 43: 241-244, 1989.
33. Tabor E: Hepatocellular carcinoma: possible etiologies in patients without serologic evidence of hepatitis B virus infection. J Med Virol 27: 1-6, 1989.
34. Doll R and Peto R: The causes of cancer. J Natl Cancer Inst 66: 1191-1308, 1981.
35. Kew MC, Rossouw E, Paterson A, Hodkinson J, Whitcutt M and Dusheiko G: Hepatitis B virus status of black women with hepatocellular carcinoma. Gastroenterol 84: 639-696, 1983.
36. Lyra LD, Reboucas G and Andrade ZA: Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterol 71: 641-645, 1976.
37. Esparz I, Rupple A, Mestan J and Kramer PH: Preactivation of macrophages in mice acutely infected with Schistosoma mansoni. Immunobiol 177: 105-119, 1988.
38. Dingemans KP and Elias EA: Changes in the hamster liver after experimental infection with Schistosoma intercalatum. An ultrastructural study. Ann Trop Med Parasitol 72: 231-242, 1978.
39. Fayes MA, Othman A, Moustapha M, Elsaadani AM, Aziz S and el-Gengehy MT: The effect of haptic haemodynamics on the size of the liver and the phagocytic activity of Kupffer cells. J Egypt Med Assoc 52: 487-494, 1989.
40. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas GL and Strickland GT: High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut 37: 105-107, 1995.